Back
Sutro Biopharma Stock Price Chart

How to hack a $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
19
STRO
Sutro Biopharma
Last Price:
$0.81
Seasonality Move:
7.03%
7 Day Trial
ALL ACCESS PASS
$
7

Former Zillow exec targets $1.3T marke
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and STRO is experiencing slight selling pressure.
Sutro Biopharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.82 | Sell |
20-day SMA: | 0.86 | Sell |
50-day SMA: | 0.84 | Sell |
200-day SMA: | 2.13 | Sell |
8-day EMA: | 0.82 | Sell |
20-day EMA: | 0.85 | Sell |
50-day EMA: | 0.92 | Sell |
200-day EMA: | 1.87 | Sell |
Sutro Biopharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 43.89 | Sell |
Chaikin Money Flow: | -94683 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.81 - 0.91) | Sell |
Bollinger Bands (100): | (0.65 - 1.59) | Sell |
Sutro Biopharma Technical Analysis
Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Sutro Biopharma Stock
Is Sutro Biopharma Stock a Buy?
-
Sutro Biopharma share price is 0.79 while STRO 8-day simple moving average is 0.82, which is a Sell signal.
-
The stock price of STRO is 0.79 while Sutro Biopharma 20-day SMA is 0.86, which makes it a Sell.
-
Sutro Biopharma 50-day simple moving average is 0.84 while STRO share price is 0.79, making it a Sell technically.
-
STRO stock price is 0.79 and Sutro Biopharma 200-day simple moving average is 2.13, creating a Sell signal.
STRO Technical Analysis vs Fundamental Analysis
Sell
19
Sutro Biopharma (STRO)
is a Sell
Is Sutro Biopharma a Buy or a Sell?
-
Sutro Biopharma stock is rated a SellThe current Sutro Biopharma [STRO] share price is $0.79. The Score for STRO is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
Sutro Biopharma Stock Info
Market Cap:
67M
Price in USD:
0.79
Share Volume:
719.6K
Sutro Biopharma 52-Week Range
52-Week High:
5.17
52-Week Low:
0.52
Sell
19
Sutro Biopharma (STRO)
is a Sell
Sutro Biopharma Share Price Forecast
-
What is the Sutro Biopharma stock price today?The Sutro Biopharma stock price is 0.79 USD today.
-
Will STRO stock go up or go down?Sutro Biopharma> share price is forecast to RISE/FALL based on technical indicators
-
Is Sutro Biopharma overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sutro Biopharma is overvalued.
Is Sutro Biopharma Stock a Buy?
-
Sutro Biopharma share price is 0.79 while STRO 8-day exponential moving average is 0.82, which is a Sell signal.
-
The stock price of STRO is 0.79 while Sutro Biopharma 20-day EMA is 0.85, which makes it a Sell.
-
Sutro Biopharma 50-day exponential moving average is 0.92 while STRO share price is 0.79, making it a Sell technically.
-
STRO stock price is 0.79 and Sutro Biopharma 200-day simple moving average is 1.87, creating a Sell signal.
Fundamental Analysis of Sutro Biopharma
Is Sutro Biopharma a good investment?
-
Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.91 per share, and an increase next year of $1.48 per share.
Technical Analysis of Sutro Biopharma
Should I short Sutro Biopharma stock?
-
STRO Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Sutro Biopharma is a Sell
-
Sutro Biopharma Relative Strength Index (RSI) is 43.89, which suggest Sutro Biopharma is oversold
-
The Bollinger Bands (25) for Sutro Biopharma is (0.81 - 0.91), which suggest Sutro Biopharma is a Sell
-
The Bollinger Bands (100) for Sutro Biopharma is (0.65 - 1.59), which suggest Sutro Biopharma is a Sell
* Sutro Biopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.